NT-proBNP Quantification via LC-MS/MS and Affinity Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing clinical assays for determining NT-proBNP concentrations are not standardized, leading to variations in results depending on the assay used, and there is a lack of an independent reference method for accurate quantification.
Innovation Solution
A method involving affinity purification of NT-proBNP, followed by enzymatic digestion and detection using liquid chromatography-mass spectrometry analysis, which allows for the accurate quantification of NT-proBNP by targeting specific peptides and using labelled peptide standards.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If sandwich immunoassays are used for NT-proBNP detection, then the assay can be performed commercially, but the results vary depending on the assay used due to lack of standardization
Solution Approach 1:
The patent replaces the immunoassay-based mechanical detection system with a mass spectrometry-based detection system. Instead of using antibodies and immunochemical reactions, the invention uses LC-MS/MS to directly detect and quantify NT-proBNP and its glycosylated forms, eliminating the variability inherent in different immunoassay platforms while maintaining commercial feasibility through established mass spectrometry technology.
Solution Approach 2:
The invention changes the detection parameter from immunoreactivity (antibody binding) to mass-to-charge ratio. By detecting the actual mass of NT-proBNP molecules and their glycosylated variants, the method provides a universal measurement that is independent of assay-specific antibody characteristics, thereby improving result consistency across different laboratories and platforms.
2Adaptability or versatility
If glycosylated forms of NT-proBNP are present in blood, then the molecular complexity increases, but existing assays cannot accurately distinguish between different glycosylation states
Solution Approach 1:
The patent applies enzymatic digestion to segment the intact NT-proBNP molecule and its glycosylated forms into smaller peptide fragments. By digesting all forms with trypsin and detecting specific peptide sequences (including glycosylated peptides), the method can distinguish between different glycosylation states while accurately quantifying the total NT-proBNP concentration, resolving the complexity rather than being obscured by it.
Solution Approach 2:
The invention introduces enzymatic digestion as an intermediary step between sample preparation and detection. The enzymes break down the complex glycosylated NT-proBNP molecules into characteristic peptide fragments that can be precisely identified and quantified by mass spectrometry, serving as a bridge that translates molecular complexity into measurable signals.
3Measurement precision
If affinity purification is performed before LC-MS analysis, then sensitivity is improved, but the process complexity increases
Solution Approach 1:
The patent employs a universal affinity purification approach using anti-NT-proBNP antibodies that can capture all forms of NT-proBNP (glycosylated and non-glycosylated) in a single step. This multi-functional capture method simplifies the overall process by handling diverse molecular forms with a single reagent system, reducing procedural complexity while maintaining high sensitivity through efficient enrichment of target analytes from complex biological matrices.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a robust and reliable approach for determining NT-proBNP concentrations, reducing variability associated with glycosylation and improving sensitivity, thus enabling more accurate diagnostic and monitoring of heart failure.
Implementation Method 1
affinity purification of NT-proBNP
Implementation Method 2
enzymatic digestion
Implementation Method 3
subjecting said isolated NT-proBNP and peptide standard to enzymatic digestion
Implementation Method 4
liquid chromatography-mass spectrometry analysis
Implementation Method 5
mass spectrometric detection
Data Source
Figure 1~2
Figure 3
Figure 4
AI summary
A reference method for quantifying the total amount of NT-proBNP in a sample,independent of its degree of glycosylation, involving LC-MS/MS analysis of a sample that has been subjected to affinity purification and subsequent digestion.